Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Increases market presence through investment in chemistry.
April 6, 2016
By: Tim Wright
Editor-in-Chief, Contract Pharma
Smithers Viscient has expanded its mass spectrometry suite, saying the increased capacity will allow it to continue to provide the high level of scientific expertise and service that its clients demand. This announcement comes less than one-year since the company moved into a new custom-built laboratory in Harrogate. “Since moving into our new state-of-the-art laboratory we have expanded our footprint and invested in both our people and cutting-edge technology to provide a superior customer service to our client base,” said David Phillips, managing director, Smithers Viscient. Smithers Viscient recently acquired a new mass spectrometer, the Absciex Triple TOF (time of flight) 5600+. This highly sensitive and accurate instrument will be paired with a front-end Shimadzu Nexera UHPLC. These advanced machines can detect down to part-per-billion levels. According to the company, this level of detection is extremely important for detailed structural characterization, an area in which more clients are requesting expertise. The new instrument will provide additional metabolite identification and quantitative analysis to support environmental fate, ecotoxicology and product development testing at Smithers Viscient. The new equipment acquisition complements Smithers Viscient’s existing technology portfolio including Q Exactive accurate mass and API5000 mass spectrometers. Smithers Viscient expects the new system to significantly expand capacity and broaden the lab’s capability to address a wider range of projects.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !